Glycotest

Business Services · New York, United States · 1-10 Employees

View Company Info for Free

Overview

Headquarters

77 Water St Ste 817, New York City, New ...

Phone Number

(484) 431-3483

Revenue

<$5 Million

Industry

Business Services Healthcare Services Research & Development Medical Laboratories & Imaging Centers
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1

About Glycotest

Glycotest Diagnostics specializes in developing unique and non-invasive blood tests aimed at detecting liver cancers and fibrosis-cirrhosis. Their innovative technology focuses on early detection of serious liver diseases, particularly for individuals at risk due to chronic liver conditions such as viral hepatitis and metabolic diseases. By utilizing proprietary biomarkers and assays, Glycotest aims to improve patient outcomes through algorithm-driven biomarker panels that analyze standard blood samples. The company targets a significant global health issue, as liver cancer is a leading cause of cancer-related deaths.Explore more
Popular Searchesglycotest IncGlycotestSIC Code 87,873NAICS Code 54,541Show more

Is Glycotest your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Glycotest

Compare insights from companies similar to Glycotest, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Glycotest

<$5M
1-10
Private
$10M
2012
N/A
<$5M
11-50
Private
$12.5M
2009
<$5M
11-50
Private
<$5M
2010
<$5M
11-50
Private
-
-
<$5M
11-50
Private
-
-
N/A
<$5M
1-10
Private
-
-
EK
Ee KhokBusiness Development Manager
<$5M
11-50
Public
<$5M
1987
JE
Jason EmbertDirector, Special Events
Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

Glycotest is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

Glycotest is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Glycotest.

Glycotest financials insights

Gather financial insights about Glycotest, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

2018

Series A

$10M

See All Glycotest's Financials Insights

Glycotest Tech Stack

A closer look at the technologies used by Glycotest

Top Business Services Companies

Frequently Asked Questions Regarding Glycotest

What is Glycotest's official website?
Glycotest's official website is www.glycotest.com
What is Glycotest's Revenue?
Glycotest's revenue is <$5 Million
What is Glycotest's SIC code?
Glycotest's SIC: 87,873
What is Glycotest's NAICS code?
Glycotest's NAICS: 54,541
How many employees does Glycotest have?
Glycotest has 1-10 employees
What industry does Glycotest belong to?
Glycotest is in the industry of: Business Services, Healthcare Services, Research & Development
What is Glycotest competition?
Glycotest top competitors include: Palmtree Clinical Research, Ddnews, Ark Bio, YAM Laboratory
What technology does Glycotest use?
Some of the popular technologies that Glycotest uses are: Google Cloud Web Serving, Google Cloud Platform, Microsoft 365, GoDaddy DNS
How do I contact Glycotest?
Glycotest contact info: Phone number: (484) 431-3483 Website: www.glycotest.com
What does Glycotest do?

Glycotest Diagnostics specializes in developing unique and non-invasive blood tests aimed at detecting liver cancers and fibrosis-cirrhosis. Their innovative technology focuses on early detection of serious liver diseases, particularly for individuals at risk due to chronic liver conditions such as viral hepatitis and metabolic diseases. By utilizi... ng proprietary biomarkers and assays, Glycotest aims to improve patient outcomes through algorithm-driven biomarker panels that analyze standard blood samples. The company targets a significant global health issue, as liver cancer is a leading cause of cancer-related deaths.Read More

Who invested in Glycotest?
Glycotest has 2 investors including Shanghai Fosun Pharmaceutical Co. , Ltd. and Fosun Pharmaceutical Co..
Is Glycotest a public company?
Glycotest is private company therefore does not currently have an official ticker symbol
See more information about Glycotest

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.